Abnormalities of the short arm of chromosome 12 in T cell prolymphocytic leukemia. 1998

F Salomon-Nguyen, and F Brizard, and M Le Coniat, and I Radford, and R Berger, and A Brizard
INSERM U 301 and SD401 No. 301 CNRS, Paris, France.

Abnormalities of the short arm of chromosome 12 are nonrandom events in T cell prolymphocytic leukemia (T-PLL). Fluorescence in situ hybridization (FISH) studies were performed in three patients with T-PLL and one patient with T cell peripheral lymphoma and rearrangement of 12p. Whereas the rearrangements of 12p were different in the four patients, a breakpoint centromeric to the ETV6 gene was present in the three T-PLL patients. In addition, loss of heterozygosity for a chromosomal segment telomeric to ETV6 with loss of the RAD52 locus was also shown by FISH studies. In contrast, the breakpoint was telomeric to ETV6 in the patient with peripheral lymphoma.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D002881 Chromosomes, Human, Pair 12 A specific pair of GROUP C CHROMOSOMES of the human chromosome classification. Chromosome 12
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015458 Leukemia, T-Cell A malignant disease of the T-LYMPHOCYTES in the bone marrow, thymus, and/or blood. Leukemia, Lymphocytic, T-Cell,Lymphocytic Leukemia, T-Cell,T-Cell Leukemia,T-Lymphocytic Leukemia,Leukemia, Lymphocytic, T Cell,T Lymphocytic Leukemia,Leukemia, T Cell,Leukemia, T Lymphocytic,Leukemia, T-Cell Lymphocytic,Leukemia, T-Lymphocytic,Leukemias, T Lymphocytic,Leukemias, T-Cell,Leukemias, T-Cell Lymphocytic,Leukemias, T-Lymphocytic,Lymphocytic Leukemia, T,Lymphocytic Leukemia, T Cell,Lymphocytic Leukemias, T,Lymphocytic Leukemias, T-Cell,T Cell Leukemia,T Lymphocytic Leukemias,T-Cell Leukemias,T-Cell Lymphocytic Leukemia,T-Cell Lymphocytic Leukemias,T-Lymphocytic Leukemias
D015463 Leukemia, Prolymphocytic A chronic leukemia characterized by a large number of circulating prolymphocytes. It can arise spontaneously or as a consequence of transformation of CHRONIC LYMPHOCYTIC LEUKEMIA. Prolymphocytic Leukemia,Leukemias, Prolymphocytic,Prolymphocytic Leukemias

Related Publications

F Salomon-Nguyen, and F Brizard, and M Le Coniat, and I Radford, and R Berger, and A Brizard
January 1986, Cancer genetics and cytogenetics,
F Salomon-Nguyen, and F Brizard, and M Le Coniat, and I Radford, and R Berger, and A Brizard
January 2004, Acta haematologica,
F Salomon-Nguyen, and F Brizard, and M Le Coniat, and I Radford, and R Berger, and A Brizard
May 2017, American journal of hematology,
F Salomon-Nguyen, and F Brizard, and M Le Coniat, and I Radford, and R Berger, and A Brizard
August 1983, Cancer genetics and cytogenetics,
F Salomon-Nguyen, and F Brizard, and M Le Coniat, and I Radford, and R Berger, and A Brizard
January 2013, Proceedings (Baylor University. Medical Center),
F Salomon-Nguyen, and F Brizard, and M Le Coniat, and I Radford, and R Berger, and A Brizard
April 2017, Hematology/oncology clinics of North America,
F Salomon-Nguyen, and F Brizard, and M Le Coniat, and I Radford, and R Berger, and A Brizard
January 1998, Cancer control : journal of the Moffitt Cancer Center,
F Salomon-Nguyen, and F Brizard, and M Le Coniat, and I Radford, and R Berger, and A Brizard
January 2006, Medical oncology (Northwood, London, England),
F Salomon-Nguyen, and F Brizard, and M Le Coniat, and I Radford, and R Berger, and A Brizard
January 1998, Ryoikibetsu shokogun shirizu,
F Salomon-Nguyen, and F Brizard, and M Le Coniat, and I Radford, and R Berger, and A Brizard
March 2009, Expert review of anticancer therapy,
Copied contents to your clipboard!